The Effect of Type 2 Diabetes Mellitus on the Short-Term Outcomes and Prognosis of Stage I–III Colorectal Cancer: A Propensity Score Matching Analysis

References

• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103. doi:10.5114/pg.2018.81072
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
   PubMed Web of Science ®Google Scholar
• Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-310912
   PubMed Web of Science ®Google Scholar
• Cheng YX, Tao W, Zhang H, Peng D, Wei ZQ. Does liver cirrhosis affect the surgical outcome of primary colorectal cancer surgery? A meta-analysis. World J Surg Oncol. 2021;19(1):167. doi:10.1186/s12957-021-02267-6
   PubMed Web of Science ®Google Scholar
• Watanabe T, Momosaki R, Suzuki S, Abo M. Preoperative rehabilitation for patients undergoing colorectal cancer surgery: a retrospective cohort study. Support Care Cancer. 2020;28(5):2293–2297. doi:10.1007/s00520-019-05061-z
   PubMed Web of Science ®Google Scholar
• Li Y, Yan Y, Dai H, et al. Mastery of type 2 diabetes prevention and treatment knowledge by general practitioners in Shanghai: a cross-sectional study. BMC Fam Pract. 2021;22(1):189. doi:10.1186/s12875-021-01538-1
   PubMed Web of Science ®Google Scholar
• Roy A, Sahoo J, Kamalanathan S, et al. Diabetes and pancreatic cancer: exploring the two-way traffic. World J Gastroenterol. 2021;27(30):4939–4962. doi:10.3748/wjg.v27.i30.4939
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–2251. doi:10.1016/S0140-6736(17)30058-2
   PubMed Web of Science ®Google Scholar
• Klil-Drori AJ, Azoulay L, Pollak MN. Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? Nat Rev Clin Oncol. 2017;14(2):85–99. doi:10.1038/nrclinonc.2016.120
   PubMed Web of Science ®Google Scholar
• Abudawood M. Diabetes and cancer: a comprehensive review. J Res Med Sci. 2019;24:94. doi:10.4103/jrms.JRMS_242_19
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–1685. doi:10.2337/dc10-0666
   PubMed Web of Science ®Google Scholar
• Guraya SY. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review. World J Gastroenterol. 2015;21(19):6026–6031. doi:10.3748/wjg.v21.i19.6026
   PubMed Web of Science ®Google Scholar
• Zhu B, Wu X, Wu B, et al. The relationship between diabetes and colorectal cancer prognosis: a meta-analysis based on the cohort studies. PLoS One. 2017;12(4):e0176068. doi:10.1371/journal.pone.0176068
   PubMed Web of Science ®Google Scholar
• Petrelli F, Ghidini M, Rausa E, et al. Survival of colorectal cancer patients with diabetes mellitus: a meta-analysis. Can J Diabetes. 2021;45(2):186–197.e2. doi:10.1016/j.jcjd.2020.06.009
   PubMed Web of Science ®Google Scholar
• Weiser MR. AJCC 8th edition: colorectal cancer. Ann Surg Oncol. 2018;25(6):1454–1455. doi:10.1245/s10434-018-6462-1
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca2
   PubMed Web of Science ®Google Scholar
• Xu B, Zhou X, Li X, Liu C, Yang C. Diabetes mellitus carries a risk of esophageal cancer: a meta-analysis. Medicine. 2017;96(35):e7944. doi:10.1097/MD.0000000000007944
   PubMed Web of Science ®Google Scholar
• Peng D, Cheng YX, Zhang W. Does Roux-en-Y construction really bring benefit of type 2 diabetes mellitus remission after gastrectomy in patients with gastric cancer? A systematic review and meta-analysis. Diabetes Ther. 2020;11(12):2863–2872. doi:10.1007/s13300-020-00934-7
   PubMed Web of Science ®Google Scholar
• Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013;56(11):1304–1319. doi:10.1097/DCR.0b013e3182a479f9
   PubMed Web of Science ®Google Scholar
• Jullumstrø E, Kollind M, Lydersen S, Edna TH. Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol. 2009;48(3):361–367. doi:10.1080/02841860802637765
   PubMed Web of Science ®Google Scholar
• Amshoff Y, Maskarinec G, Shvetsov YB, et al. Type 2 diabetes and colorectal cancer survival: the multiethnic cohort. Int J Cancer. 2018;143(2):263–268. doi:10.1002/ijc.31311
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Noroozi M, Pourhoseingholi MA, et al. Effect of metabolic syndrome and its components on survival in colorectal cancer: a prospective study. J Renal Inj Prev. 2015;4(1):15–19. doi:10.12861/jrip.2015.05
   PubMedGoogle Scholar
• Brown JC, Zhang S, Ou FS, et al. Diabetes and clinical outcome in patients with metastatic colorectal cancer: CALGB 80405 (alliance). JNCI Cancer Spectr. 2019;4(1):pkz078. doi:10.1093/jncics/pkz078
   PubMed Web of Science ®Google Scholar
• Ma YS, Yang IP, Tsai HL, et al. High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells. DNA Cell Biol. 2014;33(2):64–72. doi:10.1089/dna.2013.2161
   PubMed Web of Science ®Google Scholar
• Saito A, Kitayama J, Horie H, et al. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus. Cancer Sci. 2020;111(11):4012–4020. doi:10.1111/cas.14615
   PubMed Web of Science ®Google Scholar
• Cheng HC, Chang TK, Su WC, Tsai HL, Wang JY. Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes. Transl Oncol. 2021;14(7):101089. doi:10.1016/j.tranon.2021.101089
   PubMed Web of Science ®Google Scholar
• Lonjon G, Boutron I, Trinquart L, et al. Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg. 2014;259(1):18–25. doi:10.1097/SLA.0000000000000256
   PubMed Web of Science ®Google Scholar
• Yap R, Wilkins S, Staples M, Oliva K, McMurrick PJ. The effect of diabetes on the perioperative outcomes of colorectal cancer surgery patients. PLoS One. 2016;11(12):e0167271. doi:10.1371/journal.pone.0167271
   PubMed Web of Science ®Google Scholar
• Tan DJH, Yaow CYL, Mok HT, et al. The influence of diabetes on postoperative complications following colorectal surgery. Tech Coloproctol. 2021;25(3):267–278. doi:10.1007/s10151-020-02373-9
   PubMed Web of Science ®Google Scholar
• Kido H, Kato S, Funahashi K, et al. The metabolic parameters based on volume in PET/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis. EJNMMI Res. 2021;11(1):87. doi:10.1186/s13550-021-00831-5
   PubMed Web of Science ®Google Scholar
• Peng D, Liu XY, Cheng YX, Tao W, Cheng Y. Improvement of diabetes mellitus after colorectal cancer surgery: a Retrospective Study of Predictive factors for type 2 diabetes mellitus remission and overall survival. Front Oncol. 2021;11:694997. doi:10.3389/fonc.2021.694997
   PubMed Web of Science ®Google Scholar
• Pang QY, An R, Liu HL. Perioperative transfusion and the prognosis of colorectal cancer surgery: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):7. doi:10.1186/s12957-018-1551-y
   PubMed Web of Science ®Google Scholar